Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Billiken Angels Network
AddedFeb 16, 2024
UpdatedJun 28, 2026
Billiken Angels Network

Billiken Angels Network

Operating

Billiken Angels Network: A US-based venture capital firm offering investment management and advisory services.

Location
St. Louis, MO, US
Founded
2008
Firm
Compare
Portfolio
Employees
Website

Investments

Geneoscopy
Geneoscopy

Total Raised

$112.9M

Rounds

4

Seed$1MApril 2018
Greetabl
Greetabl

Total Raised

$2.5M

Rounds

5

Seed$1.5MJune 2017
Seed$775kJuly 2016
SeedSeptember 2015
Seed$150kOctober 2013
MedAware Solutions
MedAware Solutions

Total Raised

$2.4M

Rounds

3

Series Unknown$2.2MMarch 2016
Mentor Spaces
Mentor Spaces

Total Raised

$4.5M

Rounds

7

Seed$1.3MOctober 2015
Bonfyre
Bonfyre
Acquired

Total Raised

$10.9M

Rounds

11

Seed$147.5kSeptember 2015
Pre-Seed$30kDecember 2014
Bookalokal
Bookalokal

Total Raised

$389k

Rounds

5

SeedJune 2015
Hey Let's Train
Hey Let's Train

Total Raised

$2.7M

Rounds

2

Seed$40kJune 2015
Immunophotonics
Immunophotonics

Total Raised

$30.4M

Rounds

9

Series A$600kJanuary 2015
Series A$1.8MSeptember 2014
Kogent Surgical
Kogent Surgical

Total Raised

$36.8k

Rounds

4

Seed$15.8kDecember 2014
SeedOctober 2013
Coolfire
Coolfire

Total Raised

$20.5M

Rounds

4

Seed$3.3MOctober 2014
Kypha
Kypha

Total Raised

$24M

Rounds

15

Series UnknownAugust 2014
Series Unknown$750kAugust 2013
Material Mix
Material Mix

Total Raised

$155k

Rounds

5

Seed$15kFebruary 2014
Seed$40kAugust 2013
Helper Helper
Helper Helper

Total Raised

$200k

Rounds

4

SeedJanuary 2014
Generico
Generico

Total Raised

$1.9M

Rounds

4

SeedJanuary 2014
aisle411
aisle411

Total Raised

$9.7M

Rounds

5

Series A$6.3MSeptember 2013
BusyEvent
BusyEvent

Total Raised

$1.5M

Rounds

5

Series AFebruary 2013
EndoStim
EndoStim
Acquired

Total Raised

$79.6M

Rounds

8

Series C$9.1MJanuary 2013